https://www.indianpharmapost.com/fda-nod-to-groundbreaking-bladder-cancer-combo-therapy-for-surgery-patients-183202025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/bionxt-secures-eurasian-patent-for-breakthrough-sublingual-ms-therapy-183362025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/contineum-ms-drug-stumbles-in-mid-stage-trial-183352025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/gsks-tesaro-sues-anaptysbio-over-alleged-breach-of-cancer-drug-licence-deal-183342025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/texas-hits-sanofi-bristol-myers-squibb-with-lawsuit-over-blood-thinner-drug-efficacy-183332025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/alvotech-and-advanz-pharma-secure-european-nod-for-gobivaz-first-biosimilar-to-simponi-183322025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/mesoblast-teams-with-nih-to-launch-pivotal-trial-of-life-saving-cell-therapy-in-adults-with-severe-agvhd-183312025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/bayers-experimental-stroke-drug-could-reshape-secondary-stroke-prevention-183302025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/moderna-bags-15-billion-5-yr-loan-to-boost-financial-flexibility-183292025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-investigates-fatal-case-linked-to-rare-blood-disorder-drug-adzynma-183282025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-slaps-gene-therapy-elevidys-with-boxed-warning-after-fatal-liver-failures-183272025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/ind-swift-laboratories-receives-certifications-from-bureau-veritas-183262025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/natco-pharma-receives-7-observations-from-usfda-for-api-unit-at-manali-183252025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-receives-7-observations-from-usfda-for-goa-manufacturing-facility-183242025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/aptus-pharma-enters-into-urology-therapy-segment-183232025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/shilpa-medicare-receives-8-observations-from-usfda-for-unit-4-at-jadcherla-183222025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/marksans-pharma-inc-receives-usfda-approval-for-loperamide-hydrochloride-tablets-183212025-11-24T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-reddys-receives-eu-nod-for-avt03-biosimilar-denosumab-183372025-11-24T00:00:00+05:30always0.9